Akanda Corp. (NASDAQ:AKAN) Sees Large Increase in Short Interest

Akanda Corp. (NASDAQ:AKANGet Free Report) saw a large increase in short interest in the month of July. As of July 31st, there was short interest totaling 17,220 shares, an increase of 175.8% from the July 15th total of 6,244 shares. Based on an average trading volume of 548,622 shares, the short-interest ratio is currently 0.0 days. Approximately 4.0% of the shares of the stock are sold short.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the company. Wall Street Zen raised Akanda from a “strong sell” rating to a “sell” rating in a research note on Saturday, July 25th. Weiss Ratings lowered Akanda from a “sell (d-)” rating to a “sell (e+)” rating in a report on Monday, May 18th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Akanda has a consensus rating of “Sell”.

Read Our Latest Report on AKAN

Akanda Stock Up 28.7%

Shares of NASDAQ AKAN traded up $1.44 on Friday, hitting $6.45. The company’s stock had a trading volume of 13,847,481 shares, compared to its average volume of 895,787. The stock has a 50 day moving average of $10.71 and a 200-day moving average of $10.21. Akanda has a 12-month low of $2.30 and a 12-month high of $209.02.

Akanda (NASDAQ:AKANGet Free Report) last issued its quarterly earnings data on Tuesday, June 9th. The company reported ($317.90) earnings per share for the quarter.

About Akanda

(Get Free Report)

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

Featured Stories

Receive News & Ratings for Akanda Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akanda and related companies with MarketBeat.com's FREE daily email newsletter.